Overview
MT2 (Melanotan II) is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide hormone. Research interest centres on its non-selective activity across melanocortin receptors, particularly MC1R (associated with pigmentation pathways) and MC4R (associated with appetite-regulation pathways), making it a widely referenced tool compound in melanocortin receptor research.
MT2 10mg is planned for the Indonesia catalogue. Register your interest and we will notify you when it becomes available.
Key Research Areas
Melanocortin Receptor Signalling
MT2 is studied as a non-selective melanocortin receptor agonist, providing a research tool for probing MC1R and MC4R activation and downstream signalling cascades.
Pigmentation Pathway Research
Investigated for its interaction with MC1R on melanocytes, a receptor central to melanogenesis and pigmentation-pathway modelling.
Appetite Regulation Models
Studied for its activity at MC4R, a receptor implicated in hypothalamic appetite-regulation and energy-balance research models.
Receptor Pharmacology Research
Used as a reference agonist in comparative melanocortin receptor pharmacology studies alongside other MSH analogues.
Product Specifications
| Format | Lyophilised powder |
| Quantity | 10mg per vial |
| Purity | >98% (HPLC verified) |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Availability | Launching Soon |
| Research use | In vitro / laboratory use only |